OpenVSafe by OpenVAERS
Search V-safe

YZE-10861-59271

1 vaccination 3 coded responses 7 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
276 / NC
Registered
2021-03-10
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-10
    Registered in v-safe
  2. 2021-03-10
    Dose 1 — Janssen/Johnson & Johnson
  3. 2021-03-10
    Health check-in — day 0, dose 1
    Feeling: Good · Headache, Nausea
    Adult check-in
  4. 2021-03-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-03-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Epistaxis — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Nosebleeding
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-13
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · None
    Adult check-in
  8. 2021-09-08
    Health check-in — 6 months, dose 1
    Feeling: Fair
    Adult check-in
  9. 2022-03-13
    Survey response — 12 months, dose 1
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Covid 19 positive
    MedDRA releases: 2024-11 · check-in free text available
  10. 2022-03-13
    Report sent to call center — 12 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  11. 2022-03-17
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

DoseDateManufacturerCo-administered
12021-03-10Janssen/Johnson & Johnson

Call center

ReportedOutcomeVAERS-related outcome
2022-03-13 Successful
2022-03-17
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-12

Systemic reaction (other): Nosebleeding

2021-03-13

Systemic reaction (other): Dizziness

Release 11 — 12 months, dose 1

2022-03-13

Symptoms: Covid 19 positive

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SRODizziness ✓ ✓ ✓
SROEpistaxis ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release